Neonatal Jaundice Clinical Trial
Official title:
Implementation of a Transcutaneous Bilirubinometer in Jaundiced Newborns: a Randomised Controlled Trial
Neonatal jaundice, caused by hyperbilirubinemia, is frequently seen in healthy newborns. Assessment of the degree of jaundice is usually done visually,and if necessary serum bilirubin is investigated in a blood sample. The visual assessment is subjective and can alternatively be replaced by transcutaneous measurement.The transcutaneous bilirubinometer is a validated measurement-tool, which provides us with an estimated serum bilirubin-concentration. Little is known about the effect of the actual use of a bilirubinometer on the quality of care. Further evidence is needed to evaluate whether transcutaneous bilirubin measurements improve clinical outcome (use of blood tests, phototherapy and exchange transfusion), shorten length of stay and reduce costs. Therefore we aim to perform a Randomized controlled trial to evaluate the cost-effectiveness of implementing the use of a transcutaneous bilirubinometer in jaundiced neonates, a gestational age of 32 weeks. The assessment of jaundice by use of a transcutaneous bilirubinometer is compared to visual assessment of jaundice
Rationale:
Neonatal jaundice, caused by hyperbilirubinemia, is frequently seen in healthy newborns.
Severe hyperbilirubinemia can cause bilirubin encephalopathy (kernicterus). Assessment of the
degree of jaundice is usually done visually,and if necessary serum bilirubin is investigated
in a blood sample. The visual assessment is subjective and can alternatively be replaced by
transcutaneous measurement.The transcutaneous bilirubinometer is a validated
measurement-tool, which provides us with an estimated serum bilirubin-concentration. Little
is known about the effect of the actual use of a bilirubinometer on the quality of care.
Further evidence is needed to evaluate whether transcutaneous bilirubin measurements improve
clinical outcome (use of blood tests, phototherapy and exchange transfusion), shorten length
of stay and reduce costs.
Objective:
To evaluate the cost-effectiveness of implementing the use of a transcutaneous
bilirubinometer in jaundiced neonates.
Study design:
Randomized controlled trial
Study population:
All jaundiced newborns beyond a gestational age of 32 weeks and younger than 8 days who are
admitted at the maternity-ward or the neonatal-ward of our hospital.
Intervention:
Assessment of jaundice by use of a transcutaneous bilirubinometer.
Control:
Visual assessment of jaundice (current standard of care)
Main study parameters/endpoints:
Primary outcome variable:
The number of blood punctures for bilirubin measurement.
Secondary outcome:
Phototherapy duration in hours, amount of bilirubin-values above the exchange transfusion
limit, highest measured serum bilirubin, costs (blood test, use bilirubinometer, costs
admittance)
Nature and extent of the burden and risks associated with participation, benefit and group
relatedness:
Burden: A non-invasive transcutaneous measurement using a transcutaneous bilirubinometer
(harmless light-reflection-technique). It takes at most 5 seconds to perform the measurement
at the forehead or sternum.
Risk:It could be possible that a severe hyperbilirubinemia will be missed. This is a greater
risk in the control group, due to the fact that visual assessment is known to be unreliable.
When in doubt, the clinical team will have the authority to determine the serum
bilirubin-value.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04365998 -
BUBOLight®, a New Phototherapy Device for the Treatment of the Newborn's Jaundice
|
N/A | |
Completed |
NCT02222805 -
Effect of Timing of Umbilical Cord Clamping on Anaemia at 8 and 12 Months and Later Neurodevelopment
|
N/A | |
Completed |
NCT00692224 -
Efficacy of Zinc in Reducing Hyperbilirubinemia Among High Risk Neonates - A Double Blind Randomized Trial
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06080971 -
Persistent Neonatal Jaundice on Neonates and Childern
|
||
Recruiting |
NCT06075290 -
the Difference of Follow-up Methods of Neonatal Jaundice
|
||
Recruiting |
NCT05955144 -
Clinical Validation of the Screening Tool Picterus JP Using Different Smartphones
|
N/A | |
Recruiting |
NCT05127070 -
Evaluating the NeoTree in Malawi and Zimbabwe
|
||
Completed |
NCT02774434 -
Efficacy Study of the Draeger Jaundice Meter (JM-105) in Neonates of ≥ 24 Weeks of Gestational Age
|
N/A | |
Completed |
NCT03306004 -
Neonatal Jaundice: Knowledge, Attitudes and Practices of Mothers and Medical Trainees and Providers in and Around Ogbomosho
|
N/A | |
Terminated |
NCT05365399 -
Evaluation of a Smartphone-based Screening Tool for Neonatal Jaundice in a Ugandan Population
|
N/A | |
Recruiting |
NCT03933423 -
Home Based Phototherapy for Neonatal Jaundice
|
N/A | |
Recruiting |
NCT06087874 -
Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice
|
Phase 2 | |
Recruiting |
NCT06399146 -
Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Population in Botswana
|
N/A | |
Recruiting |
NCT03183986 -
Comparison of the Efficacy of Phototherapy Using Blue LED's With Wavelength 478 vs. 459 nm.
|
N/A | |
Withdrawn |
NCT00917007 -
Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis
|
||
Completed |
NCT06227624 -
Role of Oral Zinc in Reducing Neonatal Indirect Hyperbilirubinemia
|
Phase 3 | |
Completed |
NCT04418180 -
Fenofibrate Therapy in Pathological Unconjugated Hyperbilirubinemia in Full Term Infants
|
N/A | |
Completed |
NCT04433923 -
Aluminium Foil as an Adjuvant to Phototherapy for Pathological Unconjugated Hyperbilirubinaemia in Full Term Infants
|
N/A | |
Completed |
NCT06386731 -
Continuous Versus Intermittent Phototherapy in Treatment of Neonatal Jaundice
|
N/A | |
Not yet recruiting |
NCT05475223 -
End Tidal Carbon Monoxide (ETCO): - A Tool to Aid Identification of Neonatal Hemolysis
|
N/A |